China Earnings Roundup: China Medicine, China Biologic, 3SBio Post Strong Growth
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Guangdong-based China Medicine reported a 60 percent rise in net income to $3.2 million in the third quarter. That growth was driven by an almost 400 percent sales increase in second- and third-tier cities as a result of the Chinese government's $124 billion healthcare reforms (PharmAsia News, April 8, 2009)